American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Intuitive Surgical stock dubbed a ‘premier, high-growth’ name despite first sell rating

by admin June 10, 2025
June 10, 2025
Intuitive Surgical stock dubbed a ‘premier, high-growth’ name despite first sell rating

Intuitive Surgical Inc. (NASDAQ: ISRG) is deep in the red this morning after Deutsche Bank issued a bearish note on the biotechnology giant based out of Sunnyvale, California.

The investment firm downgraded ISRG shares on Monday to “sell” and lowered its price target on them to $440, indicating potential downside of more than 15% from current levels.

Still, famed investor Jim Cramer dubbed Intuitive Surgical stock “one of my favourite companies” as he appeared on CNBC today.

Why is Jim Cramer bullish on Intuitive Surgical stock?

Intuitive Surgical received its first sell rating on Monday, primarily because Deutsche Bank expects rising competition from more affordable remanufactured tools to prove a meaningful headwind for the company’s “da Vinci” robot system in the years ahead.

However, Jim Cramer took a more positive stance on ISRG shares on “Squawk on the Street” as the Nasdaq-listed firm continues to report strong quarters.

According to the former hedge fund manager, Intuitive Surgical stock remains worth owning as it offers exposure to a “premier, fast-growing company.”

Jim Cramer remains bullish on the biotech stock since it has a very successful track record. ISRG is one of the best stock charts over the past 20 years, he added.  

ISRG shares could benefit from razor-and-blade model

Jim Cramer likes Intuitive Surgical for its use of “razor-and-blade” business model – meaning they sell the surgical robots (like the razor) and then make ongoing revenue from selling the tools and accessories needed for each procedure (the blades).

The famed investor acknowledged that third-party companies trying to sell remanufactured tools could hurt ISRG’s profitability, but overall, he continues to see it as a high-quality business that will likely remain rewarding for investors moving forward.  

In late April, the biotech firm reported its financials for the first quarter that handily topped Street estimates.

Still, Intuitive Surgical shares remain unattractive for income investors as they do not currently pay a dividend.

Is Intuitive Surgical attractive in terms of valuation?

Investors should also note that Jim Cramer is not the only expert who’s bullish on ISRG stock at current levels.

Deutsche Bank’s bearish note on Intuitive Surgical stock arrives only days after Stephanie Link, the chief investment strategist at Hightower, loaded up on the biotech name as it’s a “secular grower in healthcare … and it’s really hard to find secular growers in healthcare.”

Link also dubbed the biotech stock attractive in terms of valuation, given it’s currently down more than 10% versus its year-to-date high.

Intuitive Surgical expects its adjusted gross profit margin to be capped at 66.5% this year, down from a tad over 69% in 2024.

However, much of that expected weakness is attributed to the impact of Trump’s new tariffs.

The post Intuitive Surgical stock dubbed a ‘premier, high-growth’ name despite first sell rating appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Here are the 3 key AI announcements Apple made at the WWDC 2025
next post
USD/MXN forecast: patterns point to more Mexican peso gains

Related Posts

Caitlin Clark’s pro salary exposes an undeniable economic...

April 23, 2024

IndiaMart shares down 19% on Jefferies downgrade: buy,...

October 21, 2024

Lego first-half sales hit record $5.4B on strong...

August 27, 2025

How 2024 US election could shape India’s IT...

November 2, 2024

Long APH: Amphenol Corp Surges Past $76 on...

January 23, 2025

Groupon stock price rare pattern points to more...

September 23, 2024

Trump Media auditor charged by SEC with ‘massive...

May 6, 2024

Why ‘wardrobing’ retail fraud soars in the summer

August 9, 2024

Southwest cuts growth plans, warning effect of Boeing...

April 27, 2024

AppLovin stock price forecast: buy the dip or...

April 15, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Why India’s gold demand is expected to dip this festive season

      September 15, 2025
    • Oil jumps 2% as OPEC agree to smaller output hike for October, sanction threats looms

      September 8, 2025
    • Weekly recap: tech titans woo Trump, Xi’s political theatre, Starmer’s reshuffle

      September 7, 2025
    • Trump reaffirms backing for Robert Kennedy amid vaccine policy turmoil

      September 7, 2025
    • South Korean president promises aid to citizens held in US immigration raid

      September 7, 2025

    Categories

    • Business (3,954)
    • Investing (2,864)
    • Latest News (2,059)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved